참고문헌
- Heino TJ, Chagin AS, Takigawa M, Savendahl L. Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation. Bone 2008;42:702-9 https://doi.org/10.1016/j.bone.2008.01.001
- Devogelaer JP. New uses of bisphosphonates : osteohenesis imperfecta. Curr Opin Pharmacol 2002;2:748-3 https://doi.org/10.1016/S1471-4892(02)00218-7
- Kos M, Luczak K, Godzinski J, Klempous J. Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg 2004;32:10-5 https://doi.org/10.1016/j.jcms.2003.07.009
- Walsh JP, Ward LC, Stewart GO, Will RK, Criddle RA, Prince RL et al. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Bone 2004;34:747-54 https://doi.org/10.1016/j.bone.2003.12.011
- Cremers S, Sparidans R, den HJ, Hamdy N, Vermeij P, Papapoulos S. A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate(pamidronate) in osteoporosis. Eur J Clin Pharmacol 2002;57:883-90 https://doi.org/10.1007/s00228-001-0411-8
- Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7 https://doi.org/10.1016/S0278-2391(03)00720-1
- Kwon YD, Yoon BW, Walter C. Bisphosphonate, is it an emerging risk factor in oral surgery? J Kor Assoc Maxillofac Plastic Recon Surg 2007;29:456-62
- Jung A, Bisaz, S, Fleisch H. The binding of pyrophosphate and two disphosphonates by hydroxyapatite crystals. Calcif. Tissue Res. 1973;11:269-80 https://doi.org/10.1007/BF02547227
- Marx RE. Oral & intravenous bisphosphonate-induced osteonecrosis of the jaw : History, Etiology, Prevention, and treatment 1st ed. Canada: Quintessence., 2007
- Rogers MJ. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003;9:2643-58 https://doi.org/10.2174/1381612033453640
- Cecchini MG, Felix R, Fleisch H, Cooper PH. Effect of bisphosphonates on proliferation and viability of mouse bone marrowderived macrophages. J Bone Miner Res 1987;2:135-42 https://doi.org/10.1002/jbmr.5650020209
- Hughes DE, MacDonald BR, Russell RG, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 1989;83:1930-5 https://doi.org/10.1172/JCI114100
- Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998;13:581-9 https://doi.org/10.1359/jbmr.1998.13.4.581
- Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ et al. Alendronate mechanism of action : geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resoprtion and kinase activation in vitro. Proc Nati Acad Sci USA 1999;96:133-8 https://doi.org/10.1073/pnas.96.1.133
- van beek E, Lowik C, van der Pluijm G, Papapoulos S. The role of geranylgeranylation in bone resorption and its suprression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 1999;14:722-9 https://doi.org/10.1359/jbmr.1999.14.5.722
- Reszka AA, Halasy-Nagy JM, Masarachia, PJ, Rodan GA. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst 1 kinase during apoptosis. J. Biol. Chem. 1999;274:34967-73 https://doi.org/10.1074/jbc.274.49.34967
- Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999;104:1363-74 https://doi.org/10.1172/JCI6800
- Fromigue O, Body JJ. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 2002;25:539-46 https://doi.org/10.1007/BF03345497
- Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004;25:4105-15 https://doi.org/10.1016/j.biomaterials.2003.11.024
- Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 1997;100:1475-80 https://doi.org/10.1172/JCI119668
- Moreno GC, Serrano S, Nacher M, Farre M, Diez A, Marinoso ML et al. Effect of alendronate on cultured normal human osteoblasts. Bone 1998;22:233-9 https://doi.org/10.1016/S8756-3282(97)00270-6
- Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.Cancer Res 2000;60:6001-7
- Qiao C, Xu W, Zhu W, Hu J, Qian H, Yin Q et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008;32:8-15 https://doi.org/10.1016/j.cellbi.2007.08.002
- von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 2005;26:6941-9 https://doi.org/10.1016/j.biomaterials.2005.04.059
- Shani M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993;91:2004-11 https://doi.org/10.1172/JCI116422
- Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34 https://doi.org/10.1016/j.joms.2004.02.004
- Frank O, Heim M, Jakob M, Barbero A, Schafer D, Bendik I et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 2002;85:737-46 https://doi.org/10.1002/jcb.10174
- Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Porras AG. Clinical pharmacology of alendronate sodium. Osteoporosis International 1993;3:13-16 https://doi.org/10.1007/BF01623002